Patents by Inventor Anne Phelan

Anne Phelan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT
    Publication number: 20210002262
    Abstract: The present invention relates to novel treatments of fibrotic diseases, including, inter alia, fibrosis of the lung, liver and kidney, and to substituted-cyanopyrrolidines of formula (I) having activity as inhibitors of ubiquitin specific peptidase 30 (USP30), and compositions containing said inhibitors, for use in said treatments (I).
    Type: Application
    Filed: March 5, 2019
    Publication date: January 7, 2021
    Inventors: Paul William THOMPSON, Anne PHELAN, Martin Lee STOCKLEY, Mark Ian KEMP
  • Uses of transport proteins
    Publication number: 20040142900
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Application
    Filed: February 26, 2004
    Publication date: July 22, 2004
    Applicant: Phogen Limited
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan
  • Uses of transport proteins
    Patent number: 6734167
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: May 11, 2004
    Assignee: Phogen Limited
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan
  • Uses of transport proteins
    Publication number: 20020155988
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Application
    Filed: December 20, 2000
    Publication date: October 24, 2002
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan